Dr. Tiziana Di Martino

Q-linea

Combating the threat of antimicrobial resistance: The promising rapid tests for antimicrobial susceptibility

In this video, Dr. Tiziana Di Martino, chief medical officer at Q-linea, discusses the importance of rapid antimicrobial susceptibility testing (AST) and explains the growing need for accurate minimum inhibitory concentration (MIC) results. Di Martino also explores the key benefits of rapid AST technology and how an MIC is utilized within clinical practice to help guide vital antimicrobial treatments to patients.



LIKE 2
Dr. Tiziana Di Martino
Clinical Laboratory Diagnostics Antimicrobial susceptibility

Dr. Tiziana Di Martino

Biography

Dr. Tiziana Di Martino, chief medical officer, Q-linea More

Dr. Tiziana Di Martino

Q-linea

Dr. Tiziana Di Martino has served as chief medical officer at Q-linea since April 2019. Martino has over 18 years’ overall experience in clinical practice, research, and medical/clinical affairs positions within the microbial diagnostic industry. Prior to joining Q-linea, Martino served as regional medical affairs manager at Abbott Molecular, clinical and scientific affairs manager EMEA at Abbott Point of Care, and Head of Clinical Development EMEA at Accelerate Diagnostics. In these roles she has successfully managed clinical projects related to new product launches. Martino holds an MD degree from Università Cattolica del Sacro Cuore in Rome (2003), an MSc in Toxicology from University of Surrey (2011) and an MBA degree from London Business School (2014).